Apartes Pharmaceuticals's latest lobbying report covers Q2 2026, at $290K. Its first report covers Q2 2026; the issues it reports most are Health Issues.

Apartes Pharmaceuticals

Latest quarter: $290K; Q2 2026 · 1 reports
Last 12 months: $290K; Last 1 quarters
vs last quarter: No record; Q2 2026 against the quarter before
First report: Q2 2026; The first quarter a report named it

Lobbying by quarter

Apartes Pharmaceuticals lobbying by quarter
Quarter	Amount	Reports
Q2 2026	$290K	1

Policy issues the reports name

Health issues1 reports

A report that names several issues counts once for each.

Who was lobbied

Health & Human Services, Dept of (HHS)1 reports
HOUSE OF REPRESENTATIVES1 reports
SENATE1 reports

Firms it paid

Firm
J M Burkman & Associates	$290K	1 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

	Filed by		Issues
07/17for Q2	J M Burkman & Associates	$290K	Health issues
05/27for Q2	J M Burkman & Associates	Under $5,000	Health issues